| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Emster Kurt Von is a Director at PCVX, with reported holdings spanning 4 companies. Recent filings cover 5 purchases and 47 sales. Those positions are worth an estimated $34.6M at current prices.
Our model assigns Emster Kurt Von a middling insider score of 62/100, based on 3 past trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of -2.5%.
Emster Kurt Von's largest disclosed position is in CRSP as Director, worth about $34.6M. The recent filings there lean toward selling, a net 1,382,466 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 14, 2017 | CRSP Crispr Therapeutics AG | Director | Sell | 69,859 | $16.84 | $1,176,709.83 | -2.9% | |
| Jul 12, 2017 | CRSP Crispr Therapeutics AG | Director | Sell | 31,992 | $16.56 | $529,937.60 | -1.3% | |
| Jul 5, 2017 | CRSP Crispr Therapeutics AG | Director | Sell | 4,254 | $16.26 | $69,170.04 | -0.2% | |
| Jun 29, 2017 | CRSP Crispr Therapeutics AG | Director | Sell | 43,202 | $16.90 | $730,124.88 | -1.7% | |
| Jun 27, 2017 | CRSP Crispr Therapeutics AG | Director | Sell | 81,435 | $17.08 | $1,390,611.45 | -3.2% | |
| Jun 23, 2017 | CRSP Crispr Therapeutics AG | Director | Sell | 32,368 | $16.23 | $525,302.10 | -1.2% | |
| Oct 24, 2016 | CRSP Crispr Therapeutics AG | Director | Buy | 56,000 | $14.00 | $784,000.00 | +2.2% |